CD274 and neoplasm: Nowadays, the predictive markers of immunotherapy mainly focus on PD-L1, tumor mutation load (TMB) [14], microsatellite high instability (MSI-H), DNA mismatch repair deficiency (dMMR) [15], plasma circulating tumor DNA (ctDNA) [16], and so on.